Innate Immunity
Innate Immunity(先天免疫)
Innate Immunity 相关产品(557)
- GC44156MeOSuc-AAPV-pNACAS: 70967-90-7纯度: >98.00%
A substrate for neutrophil elastase and proteinase 3
- GC44157MeOSuc-Ala-Ala-Pro-Val-AMCCAS: 72252-90-5纯度: >98.00%
A fluorogenic substrate for certain elastases
- GC44212MK-886 (sodium salt)CAS: 118427-55-7纯度: >99.00%
A potent, selective inhibitor of 5-lipoxygenase-activating protein (FLAP)
- GC44382Neuropeptide Y (1-24) (human, rat) (trifluoroacetate salt)纯度: >95.00%
An N-terminal fragment of NPY
- GC44388NF-κB ControlCAS: 201608-17-5纯度: >95.00%
A negative control peptide used with NF-κB inhibitor
- GC44696Prolyl-glycyl-proline Peptide纯度: >95.00%
A biomarker for chronic obstructive pulmonary disease and cystic fibrosis
- GC44820Resveratrol-3-O-Sulfate (sodium salt)CAS: 858127-11-4纯度: >95.00%
An active metabolite of resveratrol
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44140 | MCTR3 | 1784701-63-8 | >98.00% | |
A specialized pro-resolving mediator | ||||
| GC44156 | MeOSuc-AAPV-pNA | 70967-90-7 | >98.00% | |
A substrate for neutrophil elastase and proteinase 3 | ||||
| GC44157 | MeOSuc-Ala-Ala-Pro-Val-AMC | 72252-90-5 | >98.00% | |
A fluorogenic substrate for certain elastases | ||||
| GC44212 | MK-886 (sodium salt) | 118427-55-7 | >99.00% | |
A potent, selective inhibitor of 5-lipoxygenase-activating protein (FLAP) | ||||
| GC44237 | MMP-9 Inhibitor I | 206549-55-5 | >95.00% | |
An inhibitor of MMP-9 | ||||
| GC44302 | N-acetyl-Pro-Gly-Pro Peptide | - | >95.00% | |
A neutrophil chemoattractant | ||||
| GC44376 | Neuromedin N (trifluoroacetate salt) | - | >95.00% | |
A neurotensin-like neuropeptide | ||||
| GC44382 | Neuropeptide Y (1-24) (human, rat) (trifluoroacetate salt) | - | >95.00% | |
An N-terminal fragment of NPY | ||||
| GC44388 | NF-κB Control | 201608-17-5 | >95.00% | |
A negative control peptide used with NF-κB inhibitor | ||||
| GC44505 | Oleyl Anilide | 5429-85-6 | >95.00% | |
An ACAT inhibitor | ||||
| GC44540 | PAF C-16 Carboxylic Acid | 129879-41-0 | >95.00% | |
PAF with a reactive carboxylic acid group | ||||
| GC44541 | PAF C-18 | 74389-69-8 | >97.00% | |
A natural PAF analog | ||||
| GC44579 | PCTR1 | 1810710-59-8 | >96.00% | |
A specialized pro-resolving mediator | ||||
| GC44580 | PCTR2 | 1810710-63-4 | >96.00% | |
A specialized pro-resolving mediator | ||||
| GC44581 | PCTR3 | 1810710-69-0 | >96.00% | |
A specialized pro-resolving mediator | ||||
| GC44590 | Pellitorine | 18836-52-7 | >98.00% | |
An amide alkaloid with diverse biological activities | ||||
| GC44633 | Phosphatidylserines (bovine) | 1446756-47-3 | >98.00% | |
A glycerophospholipid | ||||
| GC44696 | Prolyl-glycyl-proline Peptide | - | >95.00% | |
A biomarker for chronic obstructive pulmonary disease and cystic fibrosis | ||||
| GC44794 | Pyrrophenone | 341973-06-6 | >99.50% | |
Inhibitor of cPLA 2 | ||||
| GC44802 | R-8507 | 338773-13-0 | >98.00% | |
An antagonist of TNF-α receptor signaling | ||||
| GC44818 | Resolvin D4 | 1025684-60-9 | >95.00% | |
A pro-resolving mediator | ||||
| GC44820 | Resveratrol-3-O-Sulfate (sodium salt) | 858127-11-4 | >95.00% | |
An active metabolite of resveratrol | ||||
| GC44839 | Ridaifen-B | 886465-70-9 | >98.00% | |
An analog of tamoxifen | ||||
| GC44851 | Rosiglitazone (potassium salt) | 316371-84-3 | >98.00% | |
A PPARγ agonist | ||||